BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712
77 results:

  • 1. Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review.
    Li C; Li K; Zhong S; Tang M; Shi X; Bao Y
    Crit Rev Oncol Hematol; 2024 Feb; 194():104227. PubMed ID: 38220124
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis.
    Jablonska PA; Muniz T; Ribeiro M; Liu ZA; Ye XY; Devaraja K; Laperriere N; Millar BA; Conrad T; Kongkham P; Butler M; Shultz DB
    J Neurooncol; 2023 Aug; 164(1):199-209. PubMed ID: 37552363
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Deuterium Magnetic Resonance Spectroscopy Quantifies tumor Fraction in a Mouse Model of a Mixed Radiation Necrosis / GL261-Glioblastoma Lesion.
    Song KH; Ge X; Engelbach J; Rich KM; Ackerman JJH; Garbow JR
    Mol Imaging Biol; 2024 Feb; 26(1):173-178. PubMed ID: 37516675
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
    Moore-Palhares D; Chen H; Keith J; Wang M; Myrehaug S; Tseng CL; Detsky J; Perry J; Lim-Fat MJ; Heyn C; Maralani P; Lipsman N; Das S; Sahgal A; Soliman H
    J Neurooncol; 2023 Jul; 163(3):541-551. PubMed ID: 37256526
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Safety and efficacy of Cesium-131 brachytherapy for brain tumors.
    Bander ED; Kelly A; Ma X; Christos PJ; Wernicke AG; Stieg PE; Trichter S; Knisely JPS; Ramakrishna R; Schwartz TH
    J Neurooncol; 2023 Jun; 163(2):355-365. PubMed ID: 37249824
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Schwannoma of the radial nerve: a case report.
    Hamdaoui J; Elkamch H; Gharib N; El Mazouz S; Abbassi A; Hafidi J
    Pan Afr Med J; 2022; 43():139. PubMed ID: 36762153
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small cell Lung Cancer, Melanoma, and Renal cell Carcinoma Brain Metastases.
    Lehrer EJ; Kowalchuk RO; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Fakhoury KR; Rusthoven CG; Mathieu D; Trudel C; Malouff TD; Ruiz-Garcia H; Bonney P; Hwang L; Yu C; Zada G; Patel S; Deibert CP; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Harmsen WS; Jones BM; Sharma S; Ahluwalia MS; Sheehan JP; Trifiletti DM
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):858-868. PubMed ID: 36690161
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 Patients.
    Lehrer EJ; Gurewitz J; Bernstein K; Kondziolka D; Fakhoury KR; Rusthoven CG; Niranjan A; Wei Z; Lunsford LD; Malouff TD; Ruiz-Garcia H; Peterson JL; Bonney P; Hwang L; Yu C; Zada G; Deibert CP; Prasad RN; Raval RR; Palmer JD; Patel S; Picozzi P; Franzini A; Attuati L; Mathieu D; Trudel C; Lee CC; Yang HC; Jones BM; Green S; Ahluwalia MS; Sheehan JP; Trifiletti DM
    Neurosurgery; 2022 Dec; 91(6):872-882. PubMed ID: 36255215
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Machine learning imaging applications in the differentiation of true tumour progression from treatment-related effects in brain tumours: A systematic review and meta-analysis.
    Bhandari A; Marwah R; Smith J; Nguyen D; Bhatti A; Lim CP; Lasocki A
    J Med Imaging Radiat Oncol; 2022 Sep; 66(6):781-797. PubMed ID: 35599360
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Distinguishing tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
    Feng A; Yuan P; Huang T; Li L; Lyu J
    Acad Radiol; 2022 Sep; 29(9):1320-1331. PubMed ID: 34896001
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Ga-68 PSMA PET/CT in recurrent high-grade gliomas: evaluating PSMA expression in vivo.
    Kumar A; ArunRaj ST; Bhullar K; Haresh KP; Gupta S; Ballal S; Yadav M; Singh M; Damle NA; Garg A; Tripathi M; Bal C
    Neuroradiology; 2022 May; 64(5):969-979. PubMed ID: 34648046
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
    Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
    Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Risk of radiation necrosis after stereotactic radiosurgery for melanoma brain metastasis by anatomical location.
    Choi S; Hong A; Wang T; Lo S; Chen B; Silva I; Kapoor R; Hsiao E; Fogarty GB; Carlino MS; Menzies AM; Long GV; Shivalingam BS
    Strahlenther Onkol; 2021 Dec; 197(12):1104-1112. PubMed ID: 34114045
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Renal Primitive Neuroectodermal tumor With Inferior Vena Cava Thrombus: Case Series and Literature Review of a Rare but Challenging Entity.
    Xu C; Sun Z; Xiao R; He W; Ma L
    Clin Genitourin Cancer; 2021 Oct; 19(5):e273-e279. PubMed ID: 33941490
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review.
    Kulinich DP; Sheppard JP; Nguyen T; Kondajji AM; Unterberger A; Duong C; Enomoto A; Patel K; Yang I
    Acta Neurochir (Wien); 2021 Jul; 163(7):1921-1934. PubMed ID: 33796887
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas.
    Hadi I; Reitz D; Bodensohn R; Roengvoraphoj O; Lietke S; Niyazi M; Tonn JC; Belka C; Thon N; Nachbichler SB
    Radiat Oncol; 2021 Feb; 16(1):40. PubMed ID: 33622365
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Differentiation of recurrent glioblastoma from radiation necrosis using diffusion radiomics with machine learning model development and external validation.
    Park YW; Choi D; Park JE; Ahn SS; Kim H; Chang JH; Kim SH; Kim HS; Lee SK
    Sci Rep; 2021 Feb; 11(1):2913. PubMed ID: 33536499
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
    Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
    Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The eighth version of American Joint Committee on Cancer nodal classification for high grade pancreatic neuroendocrine tumor should be generalized for the whole population with this disease.
    Li MX; Wang HY; Yuan CH; Ma CL; Jiang B; Li L; Zhang L; Zhao H; Cai JQ; Xiu DR
    Medicine (Baltimore); 2020 Sep; 99(37):e22089. PubMed ID: 32925749
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Fractionated Stereotactic Sequential Boost in a Selected Cohort of Glioblastoma Patients: A Mono-institutional Analysis.
    Marchionni A; Palumbo I; Montesi G; Bini V; Zucchetti C; Cenci N; Chiarini P; Saccia S; Aristei C; Lupattelli M
    Anticancer Res; 2020 Jun; 40(6):3387-3393. PubMed ID: 32487635
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.